Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Biophage Pharma

Biophage Pharma
1995 FOUNDED
M&A STATUS
M&A LATEST DEAL TYPE
2 FINANCING ROUNDS
Description

Developer of phage-based biotechnology product. The company is focused on the development of phage-based technologies for the detection and management of pathogenic bacteria. It operates two divisions: a therapeutic division involved in the management of bacterial contaminations in the medical, veterinary and environmental; and a biosensors division dedicated to the development and commercialization of novel biosensors.

Formerly Known As
Almont Capital
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Discovery Tools (Healthcare)
Other Pharmaceuticals and Biotechnology
Acquirer
Phagelux Canada
Primary Office
  • 6100 Royalmount
  • Montreal, Quebec H4P 2R2
  • Canada

Biophage Pharma Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Biophage Pharma‘s full profile, request access.

Request full access to PitchBook

Biophage Pharma Executive Team (4)

Name Title Board
Seat
Contact
Info
Theodore Rousseau Chief Executive Officer

3 Former Executives

You’re viewing 1 of 4 executives. Get the full list »